Related Experiment Video
Updated: Jun 17, 2026
06:30
Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
The 'neuroadrenergic hypothesis' in hypertension: current evidence
Guido Grassi1, Gino Seravalle, Fosca Quarti-Trevano
1Clinica Medica, Ospedale S. Gerardo dei Tintori, Via Pergolesi 33, 20052 Monza, Milan, Italy. guido.grassi@unimib.it
Experimental Physiology
|December 17, 2009
Summary
Sympathetic nervous system activation is linked to hypertension progression and organ damage in humans. Further research is needed to understand the causes of this sympathetic overdrive and develop targeted therapies.
Area of Science:
- Cardiovascular Physiology
- Neuroendocrinology
- Hypertension Research
Background:
- Sympathetic neural mechanisms are implicated in hypertension development and progression.
- Sympathetic activation is observed in hypertensive patients, correlating with blood pressure elevation.
- This activation contributes to target organ damage, including cardiac and vascular changes.
Purpose of the Study:
- To review the role of the sympathetic nervous system in experimental and human hypertension.
- To elucidate the features, mechanisms, and effects of sympathetic overdrive in hypertension.
- To highlight emerging therapeutic strategies targeting adrenergic overdrive.
Main Methods:
- Review of existing data from experimental animal models and human studies.
- Analysis of direct assessments of human adrenergic cardiovascular drive.
- Examination of evidence for sympathetic participation in hypertension-related organ damage.
Main Results:
- Sympathetic activation is a key feature of human hypertension, proportional to blood pressure.
- Sympathetic overdrive contributes to cardiac and vascular target organ damage.
- The precise causes of sympathetic activation in hypertension remain unclear, with potential roles for reflex modulation and metabolic factors.
Conclusions:
- Sympathetic neural mechanisms play a significant role in hypertension.
- Understanding the causes of sympathetic activation is crucial for developing effective treatments.
- Future research will focus on therapeutic interventions to reduce adrenergic overdrive.
Related Concept Videos
01:18Neural Regulation of Blood Pressure
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...